| Impact of neoadjuvant chemotherapy on pathological stage and survival in sarcomatoid bladder cancer. AM Roy, K Jatwani, V Muthusamy Kumarasamy, S Perimbeti, C Jiang, ... Journal of Clinical Oncology 41 (6_suppl), 530-530, 2023 | 1 | 2023 |
| Trends in preferred place of death for prostate cancer in the United States from 2003 to 2020: Analysis of CDC WONDER database. K Jatwani, M Sukaina, AA Khosla, R Singh, N Singh, KS Walia, A Patel, ... Journal of Clinical Oncology 42 (4_suppl), 231-231, 2024 | | 2024 |
| Analysis of a national database to evaluate place-of-death preferences among patients with bladder cancer in the United States of America from 2003 to 2020. K Jatwani, M Sukaina, AA Khosla, RJ Patel, V Muthusamy Kumarasamy, ... Journal of Clinical Oncology 42 (4_suppl), 580-580, 2024 | | 2024 |
| Trends and disparities in hospice care utilization in testicular cancer in the United States of America from 2003 to 2020: Analysis of CDC WONDER database. K Jatwani, M Sukaina, AA Khosla, R Singh, T Garg, R Chahal, A Patel, ... Journal of Clinical Oncology 42 (4_suppl), 504-504, 2024 | | 2024 |
| Impact of state health disparity on lung, breast, and prostate cancer incidence and mortality in the United States. V Muthusamy Kumarasamy, YC Lee, AM Roy, K Jatwani, KY Chang, ... Journal of Clinical Oncology 41 (16_suppl), e18639-e18639, 2023 | | 2023 |
| Role of chemotherapy in early-stage hormone receptor positive HER2-negative (HR+) breast cancer patients with variant histology. AM Roy, K Catalfamo, K Attwood, V Muthusamy Kumarasamy, K Gupta, ... Journal of Clinical Oncology 41 (16_suppl), e12514-e12514, 2023 | | 2023 |
| Pembrolizumab (Pem) in metastatic castration-resistant prostate cancer (mCRPC): Experience from a comprehensive cancer center. AM Roy, B Farmer, V Muthusamy Kumarasamy, K Jatwani, EG Levine, ... Journal of Clinical Oncology 41 (6_suppl), 113-113, 2023 | | 2023 |
| Neoadjuvant chemotherapy plus radical cystectomy (NAC-RC) versus trimodality therapy (TMT) in early-stage small cell bladder cancer: Comparison of outcomes. K Jatwani, AM Roy, K Attwood, A George, S Perimbeti, C Jiang, MS Faisal, ... Journal of Clinical Oncology 41 (6_suppl), 476-476, 2023 | | 2023 |
| Neoadjuvant chemotherapy (NAC) versus adjuvant chemotherapy (AC) in patients with clinically node-positive upper tract urothelial cancer (UTUC) who underwent radical … K Jatwani, AM Roy, K Attwood, A George, MS Faisal, ... Journal of Clinical Oncology 41 (6_suppl), 486-486, 2023 | | 2023 |
| Radical nephroureterectomy followed by adjuvant chemotherapy (RNU-AC) versus observation (RNU-O) in early-stage upper urinary tract cancers with variant histology (UUTC-VH). K Jatwani, V Muthusamy Kumarasamy, AM Roy, K Attwood, A George, ... Journal of Clinical Oncology 41 (6_suppl), 487-487, 2023 | | 2023 |
| The Emergence of Cancer Stem Cells in Early Diagnosed Prostate Cancer VM Kumarasamy, CS Lee, S Mittan Oncology Times 44 (21), 15-16, 2022 | | 2022 |
| Morphological spectrum of lesions in renal biopsies with diagnostic role of Immunofluorescence : A study in a tertiary care centre V Venkatesh, V Malaichamy, V MK Annals of Pathology and Laboratory Medicine 6 (10), A519-524, 2019 | | 2019 |
| Accentuation of general anaesthetic activity of ketamine by glutamate NMDA (N-methyl D-aspartate) receptor antagonist MS Umamageswari, NS Kumar International Journal of Basic & Clinical Pharmacology 7 (11), 2132-2137, 2018 | | 2018 |
